Related Experiment Videos

Bactericidal activity of normal human serum against Morganella, Proteus, and Providencia strains

U Nawrot1, G Mokracka-Latajka, J Grzybek-Hryncewicz

  • 1Department of Microbiology, Medical Academy, Wrocław, Poland.

Acta Microbiologica Polonica
|January 1, 1995
PubMed

Insights

Human serum effectively kills Proteus, Providencia, and Morganella bacteria. Its bactericidal action involves complement pathways and lysozyme, with varying mechanisms depending on the bacterial strain.

Area of Science:

  • Microbiology
  • Immunology

Background:

  • Proteus, Providencia, and Morganella are Gram-negative bacteria.
  • Human serum possesses antimicrobial properties.

Purpose of the Study:

  • To investigate the susceptibility of Proteus, Providencia, and Morganella strains to human serum.
  • To elucidate the mechanisms underlying the bactericidal action of human serum against these bacteria.

Main Methods:

  • Bacterial survival was assessed after incubation with 50% human serum for 1 and 3 hours.
  • Susceptible strains were tested with serum lacking classical or alternative complement pathways, or with lysozyme removed.

Main Results:

  • Human serum exhibited bactericidal activity against the tested strains.
  • Mechanisms involved complement activation via classical and/or alternative pathways, with lysozyme playing a crucial, strain-dependent role.
  • Some strains required lysozyme for killing, while others were killed effectively without it.

Conclusions:

  • The bactericidal effect of human serum on Proteus, Providencia, and Morganella is mediated by complement and lysozyme.
  • Both classical and alternative complement pathways contribute to serum's bactericidal activity.
  • Lysozyme's necessity varies, highlighting complex interactions in innate immunity.

Related Concept Videos